Innate Pharma (IPHA) Assets (2017 - 2026)
Innate Pharma (IPHA) reported Assets of $40.36 million for the quarter ended Jun 30, 2026, down 61.6% from $105.2 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Assets (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Assets of $70.86 million, down 41.0% from the prior year.
- Assets has declined for seven consecutive years, with a five-year compound annual growth rate of -27.4% (years ended Dec 2020 to Dec 2025).
- By year, Assets came in at $120.2 million in the year ended Dec 31, 2024 (-39.7%), $199.24 million in the year ended Dec 31, 2023 (-9.1%), $219.08 million in the year ended Dec 31, 2022 (-28.4%) and $306.01 million in the year ended Dec 31, 2021 (-12.8%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Assets in data going back to the quarter ended Dec 31, 2017.
- Across the past five years, year-over-year decline in Assets ran from 7.3% in the quarter ended Dec 31, 2023 to 61.6% in the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - | 39.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.66 Mn |
| Dec 31, 2025 | 73.68 Mn |
| Jun 30, 2025 | 108.99 Mn |
| Dec 31, 2024 | 115.57 Mn |
| Jun 30, 2024 | 162.23 Mn |
| Dec 31, 2023 | 193.90 Mn |
| Jun 30, 2023 | 216.33 Mn |
| Dec 31, 2022 | 212.46 Mn |
| Jun 30, 2022 | 292.95 Mn |
| Dec 31, 2021 | 302.94 Mn |
| Jun 30, 2021 | 316.85 Mn |
| Dec 31, 2020 | 378.13 Mn |
| Jun 30, 2020 | 374.61 Mn |
| Dec 31, 2019 | 449.62 Mn |
| Dec 31, 2018 | 516.19 Mn |
| Dec 31, 2017 | 304.54 Mn |
API Access
Innate Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();